Marinus Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
MRNS on Nasdaq
Location
5 Radnor Corporate Center Suite 500, 100 Matsonford Rd, Radnor, Pennsylvania

Insiders trading volume in the past year

Marinus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott Braunstein CHAIRMAN AND CEO, Director $337K -$132K -28% Aug 5, 2024
Timothy M. Mayleben Director $104K Jun 18, 2024
Steven Pfanstiel Cfo And Coo $90.1K -$36.1K -28.6% Aug 5, 2024
Joseph Hulihan Chief Medical Officer $82.2K -$33.5K -29% Aug 5, 2024
Christina Shafer Chief Commercial Officer $76.8K -$24.9K -24.5% Aug 5, 2024
Martha E. Manning Svp, Gen. Counsel & Corp. Sec. $68.1K -$22.2K -24.6% Aug 5, 2024
Sarah B. Noonberg Director $60.3K Jun 18, 2024
Marvin Johnson Director $60.3K Jun 18, 2024
Christine Silverstein Director $60.3K Jun 18, 2024
Nicole Vitullo Director $57.5K Feb 4, 2022
Sara Nochur Director $56.7K Jun 18, 2024
H. Fischer Seth Director $55.3K Jun 18, 2024
Elan Ezickson Director $53.5K Jun 18, 2024
Charles Austin Director $52.1K Jun 18, 2024
Michael R. Dougherty Director $29.6K Feb 4, 2022
Santiago Arroyo Director $24.6K Feb 4, 2022

Recent Insider Transactions by Companies or Individuals for Marinus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.